microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer

BACKGROUND: One-third of cervical cancer patients are still diagnosed at advanced stages. The five-year survival rate is decreased in about 50% of advanced stage cervical cancer patients worldwide, and the clinical outcomes are remarkably varied and difficult to predict. One of the miRNAs known to b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Park, Sunyoung, Kim, Jungho, Eom, Kiyoon, Oh, Sehee, Kim, Sunghyun, Kim, Geehyuk, Ahn, Sungwoo, Park, Kwang Hwa, Chung, Dawn, Lee, Hyeyoung
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501303/
https://ncbi.nlm.nih.gov/pubmed/31060525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5620-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares